KIN - Kindred Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
384.66M
Enterprise Value 3
317.94M
Trailing P/E
N/A
Forward P/E 1
-7.45
PEG Ratio (5 yr expected) 1
-0.17
Price/Sales (ttm)
92.00
Price/Book (mrq)
4.04
Enterprise Value/Revenue 3
76.04
Enterprise Value/EBITDA 6
-5.17

Trading Information

Stock Price History

Beta (5Y Monthly) 0.40
52-Week Change 31.48%
S&P500 52-Week Change 325.98%
52 Week High 311.35
52 Week Low 35.96
50-Day Moving Average 38.62
200-Day Moving Average 37.74

Share Statistics

Avg Vol (3 month) 3128.62k
Avg Vol (10 day) 3283.69k
Shares Outstanding 539.09M
Float 30.06M
% Held by Insiders 15.86%
% Held by Institutions 167.61%
Shares Short (Dec 30, 2019) 4648.22k
Short Ratio (Dec 30, 2019) 45.81
Short % of Float (Dec 30, 2019) 42.17%
Short % of Shares Outstanding (Dec 30, 2019) 41.66%
Shares Short (prior month Nov 28, 2019) 4709.92k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,505.19%

Management Effectiveness

Return on Assets (ttm)-32.95%
Return on Equity (ttm)-61.20%

Income Statement

Revenue (ttm)4.18M
Revenue Per Share (ttm)0.11
Quarterly Revenue Growth (yoy)72.50%
Gross Profit (ttm)1.64M
EBITDA -61.45M
Net Income Avi to Common (ttm)-61.1M
Diluted EPS (ttm)-1.64
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)87.44M
Total Cash Per Share (mrq)2.24
Total Debt (mrq)20.72M
Total Debt/Equity (mrq)21.76
Current Ratio (mrq)9.30
Book Value Per Share (mrq)2.44

Cash Flow Statement

Operating Cash Flow (ttm)-55.52M
Levered Free Cash Flow (ttm)-44.46M